Matt McFarland writes for CNN that CSAIL researchers have developed a non-invasive device that uses radio waves to detect human emotion. "Imagine if the machines around you can understand when you are stressed or your emotional state is negative,” explains Prof. Dina Katabi."[It could] try to detect depression."
In an article for U.S. News & World Report, Robert Preidt writes that researchers from MIT and the University of Oxford have found that atrial fibrillation is tied to a wider range of conditions than initially thought. The researchers found that the disorder was associated with “heart disease, heart failure, kidney disease, sudden cardiac death and death from all causes.”
ABC News reporter Gillian Mohney writes that Prof. Lydia Bourouiba has captured footage of a person sneezing, showing how far sneeze droplets can travel. Bourouiba found that “large droplets tended to land within 1 to 2 meters (about 3 to 6 feet) and that small droplets could get as far as 6 to 8 meters away (19 to 26 feet).”
MIT researchers have developed a portable system that could produce biotech drugs on demand, reports Lisa Rapaport for Reuters. “The table-top machine has the potential to one day produce proteins to treat any number of a wide range of conditions like cancer, diabetes, heart attacks, and hemophilia,” writes Rapaport.
A portable device developed by MIT researchers uses programmable yeast to create drugs on demand, reports Jamie Ducharme for Boston Magazine. The device “could be a lifesaver for doctors working in vulnerable conditions, such as the battlefield, a remote village, or even an ambulance,” writes Ducharme.
MIT researchers have developed a programmable vaccine that could be used to respond to disease outbreaks, reports Ben Gruber for Reuters. The vaccine harnesses “messenger RNA, a genetic material that can be programmed to fight any viral, bacterial or parasitic disease by provoking an amplified immune response.”
Popular Science reporter Samantha Cole writes that MIT researchers have developed a laptop-sized, portable device that can produce biopharmaceuticals for doctors in remote locations. Cole explains that the device can “produce a single dose of treatment with a series of steps, using genetically engineered yeast cells as a mini 'factory' for a variety of customizable drugs.”
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a portable pharmacy that can manufacture biopharmaceuticals and modify treatments. “Instead of relying on a cocktail that already exists, you can reprogram the reactor on demand to customize the treatment,” says Prof. Timothy Lu.
In this article and video, Nature reporter Corie Lok spotlights Prof Lydia Bourouiba’s work studying the fluid dynamics of coughing and sneezing. Bourouiba explains that her research combines “fluid mechanics to problems that are relevant in health and epidemiology to understand better how pathogens are transmitted.”
A team of MIT researchers has been selected as the winner of the Koch Institute research-grant pitch competition for their work on developing a diagnostic platform for early-stage leukemia, reports Amanda Hoover for Boston.com. Hoover explains that the diagnostic method would “single out individual cells during blood tests, highlighting those affected by leukemia.”
Huffington Post reporter Carolyn Gregoire writes that MIT spinoff Synlogic is working on reprogramming gut bacteria to act as a living therapeutic. “It’s become really clear that the bacteria living in us and on us affect our bodies in a variety of different ways — in ways that we never imagined,” explains Prof. Timothy Lu.
Grad student Michael Stepner speaks with Peter O’Dowd of Here & Now about his research examining how the life expectancy gap between the rich and poor has grown. Stepner explains the research suggests an opportunity for local “policies to address these gaps and improve life expectancies for low-income Americans.”
Emily Badger and Christopher Ingraham write for The Washington Post about a study by MIT researchers that examines how poverty impacts life expectancies across the country. “What's especially striking is that the poor live even shorter lives in some places than others. They have longer life expectancies in affluent, cities with highly educated populations,” they explain.
A new study co-authored by MIT researchers finds that people who live in expensive, well-educated cities tend to live longer, reports Jim Zarroli for NPR. Zarroli explains that “the study suggests that the relationship between life expectancy and income is not iron-clad, and changes at the local level can make a big difference.”
Bloomberg News reporter John Tozzi writes about a new study co-authored by MIT researchers that finds a growing disparity between the life expectancies of rich and poor Americans. The researchers found that, “top earning Americans gained 2 to 3 years of life expectancy between 2001 and 2014, while those at the bottom gained little or nothing.”